- Home
- PRT vs FBIOP Comparison
PRT vs FBIOP Comparison
Compare PRT & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRT
- FBIOP
- Stock Information
- Founded
- PRT 2017
- FBIOP N/A
- Country
- PRT United States
- FBIOP United States
- Employees
- PRT N/A
- FBIOP 101
- Industry
- PRT Oil & Gas Production
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- PRT Energy
- FBIOP Health Care
- Exchange
- PRT Nasdaq
- FBIOP Nasdaq
- Market Cap
- PRT N/A
- FBIOP N/A
- IPO Year
- PRT N/A
- FBIOP N/A
- Fundamental
- Price
- PRT $4.02
- FBIOP $7.90
- Analyst Decision
- PRT
- FBIOP
- Analyst Count
- PRT 0
- FBIOP 0
- Target Price
- PRT N/A
- FBIOP N/A
- AVG Volume (30 Days)
- PRT 26.0K
- FBIOP N/A
- Earning Date
- PRT 05-14-2025
- FBIOP N/A
- Dividend Yield
- PRT 10.84%
- FBIOP N/A
- EPS Growth
- PRT 6.25
- FBIOP N/A
- EPS
- PRT 0.45
- FBIOP N/A
- Revenue
- PRT $6,430,197.00
- FBIOP N/A
- Revenue This Year
- PRT N/A
- FBIOP N/A
- Revenue Next Year
- PRT N/A
- FBIOP N/A
- P/E Ratio
- PRT $8.88
- FBIOP N/A
- Revenue Growth
- PRT 5.12
- FBIOP N/A
- 52 Week Low
- PRT $3.26
- FBIOP N/A
- 52 Week High
- PRT $4.63
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- PRT 57.00
- FBIOP 74.91
- Support Level
- PRT $3.83
- FBIOP $6.43
- Resistance Level
- PRT $3.98
- FBIOP $7.00
- Average True Range (ATR)
- PRT 0.10
- FBIOP 0.39
- MACD
- PRT 0.02
- FBIOP 0.09
- Stochastic Oscillator
- PRT 58.33
- FBIOP 96.95
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.